Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital (Q49647957)

21 February 2018

http://europepmc.org/abstract/MED/29254532

title

Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital (English)

1 reference

21 February 2018

http://europepmc.org/abstract/MED/29254532

author

Dyfrig A. Hughes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Gabriel Rodrigues Martins de Freitas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

Mariana Younes Tramontina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

Giacomo Balbinotto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

Isabela Heineck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

publication date

25 April 2017

1 reference

21 February 2018

http://europepmc.org/abstract/MED/29254532

published in

Value in health regional issues

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Do emergency physicians attribute drug-related emergency department visits to medication-related problems?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Adverse drug reactions in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Outcomes of Emergency Department Patients Presenting With Adverse Drug Events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Causes of drug-related problems in the emergency room of a hospital in southern Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Adverse drug reactions: a cohort study in internal medicine units at a university hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Negative clinical outcomes of medication resulting in emergency department visits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Drug-Related Morbidity and Mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Analysis of the direct cost of adverse drug reactions in hospitalised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Assessing the economic impact of adverse drug effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

The costs associated with adverse drug events among older adults in the ambulatory setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

A method for estimating the probability of adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Perception of consultation length in cardiology and its ethical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Prescription noncompliance: contribution to emergency department visits and cost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Systematic review of studies assessing the cost of adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Adverse drug events as a cause of hospital admission in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

The assessment of adverse events in hospitals in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Cost evaluation of adverse drug reactions in hospitalized patients in Taiwan: A prospective, descriptive, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Cost of adverse drug reactions in a South Indian tertiary care teaching hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Adverse drug events in emergency department patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Pharmacy records as an indicator of non-adherence to antiretroviral therapy by HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Civil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Ministry of Health's spending on drugs: program trends from 2002 to 2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

[Pharmaceutical assistance in the Brazilian public health care system]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Exceptional circumstance drug dispensing: history and expenditures of the Brazilian Ministry of Health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VHRI.2017.03.003

10.1016/J.VHRI.2017.03.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29254532 AND SRC:MED&resulttype=core&format=json

13 June 2020

1 reference